Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4665035

CC1=C(C)C(C)(C)C([Hf+2])=C1C.[Cl-].[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL28810153 0.94 CTSD (0.33) CTSD
Bromide SCHEMBL27948607 0.94 CTSD (0.33) CTSD
Fluoride Ion SCHEMBL27948671 0.94 CTSD (0.33) CTSD
SCHEMBL2230540 0.73 CTSD (0.43) CTSD
SCHEMBL1000970 0.73 CTSD (0.35) CTSD
Hydrochloric Acid SCHEMBL22660516 0.71 CTSD (0.33) CTSD
Carbon Monoxide SCHEMBL8741386 0.67 CTSD (0.36) CTSD
Hydrochloric Acid SCHEMBL7869576 0.67 CTSD (0.35) CTSD
SCHEMBL25337148 0.65 CTSD (0.30) CTSD
Hydrochloric Acid SCHEMBL21244350 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115926076-A Production method and device of polypropylene alloy 北京鑫美格工程设计有限公司 2023-04-07 CN claimed
CN-112218900-A Catalyst system comprising two hafnocene catalyst compounds 埃克森美孚化学专利公司 2021-01-12 CN claimed
US-5627247-A COMPOUNDS OF CYCLOPENTADIENE OR INDENE WITH FLUORENE AND GROUP IV METALS PHILLIPS PETROLEUM COMPANY (US) 1997-05-06 US claimed
WO-2023250240-A1 LOW COST PROCESSES OF IN-SITU MAO SUPPORTATION AND THE DERIVED FINISHED POLYOLEFIN CATALYSTS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-12-28 WO disclosed
US-20230242745-A1 Process for Production of Thermoplastic Vulcanizates using Supported Catalyst Systems and Compositions Made Therefrom EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-08-03 US disclosed
CN-112218900-B Catalyst system comprising two hafnocene catalyst compounds 埃克森美孚化学专利公司 2023-07-04 CN disclosed
CN-115926076-A Production method and device of polypropylene alloy 北京鑫美格工程设计有限公司 2023-04-07 CN disclosed
CN-112218900-A Catalyst system comprising two hafnocene catalyst compounds 埃克森美孚化学专利公司 2021-01-12 CN disclosed
US-20080281139-A1 Catalyst for Propylene Dimerization and Dimerization Method MITSUI CHEMICALS, INC. (JP) 2008-11-13 US disclosed
EP-1872853-A1 CATALYST FOR PROPYLENE DIMERIZATION AND DIMERIZATION METHOD Mitsui Chemicals, Inc. (JP) 2008-01-02 EP disclosed
US-5627247-A COMPOUNDS OF CYCLOPENTADIENE OR INDENE WITH FLUORENE AND GROUP IV METALS PHILLIPS PETROLEUM COMPANY (US) 1997-05-06 US disclosed
CN-1136286-A Catalyst composition for ethylene polymerization and copolymerization MOBIL OIL CORP (US) 1996-11-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281139-A1 Catalyst for Propylene Dimerization and Dimerization Method PPOX, PUM2, MBD2 CTSD 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.